Erratum to: Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion
Authors:
Meiou Dai, Amal A. Al-Odaini, Nadège Fils-Aimé, Manuel A. Villatoro, Jimin Guo, Ani Arakelian, Shafaat A. Rabbani, Suhad Ali, Jean Jacques Lebrun
Main text: After publication of this work [1] an error was noticed in Fig. 5c. Figure 5c shows representative images/fields of PTGS2 staining of mammary tumors derived from mice injected with parental SCP2 cells versus mice injected with p21/cyclinD1 depleted SCP2 cells. Tissue slides from the two groups of animals were stained with an anti-PTGS2 antibody. Results showed a decrease in PTGS2 staining in the cyclinD1/p21 depleted group compared to the parental group.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.